Literature DB >> 16320269

Modelling intervention effects after cancer relapses.

Juan R González1, Edsel A Peña, Elizabeth H Slate.   

Abstract

This article addresses the problem of incorporating information regarding the effects of treatments or interventions into models for repeated cancer relapses. In contrast to many existing models, our approach permits the impact of interventions to differ after each relapse. We adopt the general model for recurrent events proposed by Peña and Hollander, in which the effect of interventions is represented by an effective age process acting on the baseline hazard rate function. To accommodate the situation of cancer relapse, we propose an effective age function that encodes three possible therapeutic responses: complete remission, partial remission, and null response. The proposed model also incorporates the effect of covariates, the impact of previous relapses, and heterogeneity among individuals. We use our model to analyse the times to relapse for 63 patients with a particular subtype of indolent lymphoma and compare the results to those obtained using existing methods. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 16320269      PMCID: PMC4066387          DOI: 10.1002/sim.2394

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  18 in total

Review 1.  Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Authors:  B D Cheson; S J Horning; B Coiffier; M A Shipp; R I Fisher; J M Connors; T A Lister; J Vose; A Grillo-López; A Hagenbeek; F Cabanillas; D Klippensten; W Hiddemann; R Castellino; N L Harris; J O Armitage; W Carter; R Hoppe; G P Canellos
Journal:  J Clin Oncol       Date:  1999-04       Impact factor: 44.544

2.  Survival analysis for recurrent event data: an application to childhood infectious diseases.

Authors:  P J Kelly; L L Lim
Journal:  Stat Med       Date:  2000-01-15       Impact factor: 2.373

3.  p53 and Bcl-2 as significant predictors of recurrence and survival in rectal cancer.

Authors:  O Schwandner; T H Schiedeck; H P Bruch; M Duchrow; U Windhoevel; R Broll
Journal:  Eur J Cancer       Date:  2000-02       Impact factor: 9.162

4.  Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series.

Authors:  A López-Guillermo; F Cabanillas; P McLaughlin; T Smith; F Hagemeister; M A Rodríguez; J E Romaguera; A Younes; A H Sarris; H A Preti; W Pugh; M S Lee
Journal:  Ann Oncol       Date:  2000       Impact factor: 32.976

5.  Prolonged survival in follicular non Hodgkins lymphoma is predicted by achievement of complete remission with initial treatment: results of a long-term study with multivariate analysis of prognostic factors.

Authors:  M Davidge-Pitts; R Dansey; W R Bezwoda
Journal:  Leuk Lymphoma       Date:  1996-12

6.  rhDNase as an example of recurrent event analysis.

Authors:  T M Therneau; S A Hamilton
Journal:  Stat Med       Date:  1997-09-30       Impact factor: 2.373

7.  Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantation.

Authors:  D J Weisdorf; J W Andersen; J H Glick; M M Oken
Journal:  J Clin Oncol       Date:  1992-06       Impact factor: 44.544

8.  Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases.

Authors:  O Servitje; F Gallardo; T Estrach; R M Pujol; A Blanco; A Fernández-Sevilla; L Pétriz; J Peyrí; V Romagosa
Journal:  Br J Dermatol       Date:  2002-12       Impact factor: 9.302

9.  Local recurrence in the breast after conservative surgery--a study of prognosis and prognostic factors in 391 women.

Authors:  I Fredriksson; G Liljegren; L-G Arnesson; S O Emdin; M Palm-Sjövall; T Fornander; M Holmqvist; L Holmberg; J Frisell
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162

10.  Survival after progression in patients with follicular lymphoma: analysis of prognostic factors.

Authors:  S Montoto; A López-Guillermo; A Ferrer; M Camós; A Alvarez-Larrán; F Bosch; J Bladé; F Cervantes; J Esteve; F Cobo; D Colomer; E Campo; E Montserrat
Journal:  Ann Oncol       Date:  2002-04       Impact factor: 32.976

View more
  3 in total

1.  Parametric latent class joint model for a longitudinal biomarker and recurrent events.

Authors:  Jun Han; Elizabeth H Slate; Edsel A Peña
Journal:  Stat Med       Date:  2007-12-20       Impact factor: 2.373

2.  Dynamic Modelling and Statistical Analysis of Event Times.

Authors:  Edsel A Peña
Journal:  Stat Sci       Date:  2006-11       Impact factor: 2.901

3.  Bayesian regression model for recurrent event data with event-varying covariate effects and event effect.

Authors:  Li-An Lin; Sheng Luo; Barry R Davis
Journal:  J Appl Stat       Date:  2017-08-26       Impact factor: 1.404

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.